The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...

Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

A revolutionary advancement in cancer treatment at UH Seidman Cancer Center is dramatically reducing the time patients spend ...

Hydrogen peroxide creates a toxic environment for cancer cells. The jabs, given directly into the tumour, weaken the cells, ...

A specialist can diagnose bladder cancer using a variety of tests. “Bladder cancer can be diagnosed through a combination of ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...